Back

Regional differences in initiation of sacubitril/valsartan in HFrEF patients after hospitalisation for acute decompensated heart failure: Post-hoc analysis of the TRANSITION study

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Pharmacotherapy HFA Premium Access Heart Failure 2021

About the speaker

Photo
Associate Professor Rolf Wachter

University Hospital Leipzig, Leipzig (Germany)

738 More presentations in this session

Presentation thumbnail
Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Abstract Slides
Presentation thumbnail
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Doctor D. Moysidis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
Doctor A. Safiullina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?
Doctor H. Santos (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Initiation of sacubitril/valsartan in patients with renal impairment early after acute decompensated heart failure in the TRANSITION study
29 June 2021
thumbnail
Congress Presentation
Regional variation in heart failure treatment: an analysis of the VICTOR trial background therapy
18 May 2025
thumbnail
Congress Presentation
Real-world analysis of heart failure medication before and after hospitalization for heart failure. Data from two large cohorts in the US and Germany.
20 May 2023
thumbnail
Congress Presentation
Geographic variation in heart failure with mildly reduced or preserved ejection fraction: the FINEARTS-HF trial
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources